Keyphrases
Neuroblastoma
100%
Mesenchymal Stromal Cells
58%
Adherens Junction
58%
Cell-cell Junctions
56%
Vascular Endothelial-cadherin
56%
Endothelial Cells
47%
Phosphorylation
38%
High-risk Neuroblastoma
36%
VE-cadherin
33%
Endothelium
33%
Leukocytes
29%
Bone Marrow
28%
Guanine nucleotide Exchange Factor
24%
Rho GTPases
24%
Endothelial Junctions
22%
Minimal Residual Disease
21%
Neutrophils
20%
Neuroblastoma Cells
20%
Actin Dynamics
19%
Small Rho GTPases
19%
Vascular Integrity
19%
Cervical Carcinoma
19%
Peripheral Stem Cells
19%
Catenin
19%
Platelets
19%
Rac1
19%
Promoter Methylation
19%
Metastatic Bone
19%
Dinutuximab
19%
Signaling Complex
19%
Granulocyte Colony-stimulating Factor (G-CSF)
19%
Anticancer Agents
19%
Reconstitution
19%
Cytotoxicity
19%
Protein Tyrosine Phosphatase 1B (PTP1B)
19%
Tumor Suppressor Activity
19%
Marker Panel
19%
Iodine-131 (131I)
19%
Apheresis
19%
Bone Marrow Niche
19%
Therapeutic Implications
19%
RNA Markers
19%
123I-MIBG
19%
SHP2
19%
Hematopoietic Recovery
19%
Plasminogen Activator inhibitor-1 (PAI-1)
19%
Cytoskeleton
19%
Vascular Permeability
18%
Peripheral Blood
14%
Quantitative PCR
13%
Medicine and Dentistry
Ganglioneuroblastoma
97%
Mesenchymal Stem Cell
58%
Messenger RNA
28%
Minimal Residual Disease
21%
Neuroblastoma Cell
21%
Neutrophil
19%
Endothelium
19%
Vascular Endothelial Cadherin
19%
Anticarcinogen
19%
Granulocyte Macrophage Colony Stimulating Factor
19%
Granulocyte Colony Stimulating Factor
19%
Adherens Junction
19%
Methylation
19%
Cytotoxicity
19%
Carcinogenesis
19%
Promoter Region
19%
Dinutuximab
19%
Tumor Suppressor Protein
19%
Actin
14%
Neoplasm
13%
Tumor Cell
11%
Rho Guanine Nucleotide Binding Protein
9%
Guanine Nucleotide Exchange Factor
9%
Cell Junction
9%
Immunotherapy
8%
Metastatic Carcinoma
8%
Real-Time Polymerase Chain Reaction
8%
Patient with Neuroblastoma
7%
Tumor Progression
6%
Biopsy Technique
5%
Biochemistry, Genetics and Molecular Biology
VE-cadherin
87%
Adherens Junction
58%
Cell Junction
50%
Stromal Cell
38%
Actin
33%
Guanine Nucleotide Exchange Factor
24%
GTPase
24%
Plasminogen Activator Inhibitor-1
19%
Promoter Region
19%
Methylation
19%
Tumor Suppressor Protein
19%
Catenin
19%
Dynamics
19%
Protein Tyrosine Phosphatase
19%
Carcinogenesis
19%
Cytoskeleton
14%
Leukocyte
12%
Thrombin
9%
Messenger RNA
9%
Tumor Progression
8%
Vascular Endothelial Growth Factor
6%
Vascular Endothelial Growth Factor A
6%
Cancer Cell
5%